PETALING JAYA: AmInvest Research expects Ancom Nylex Bhd to register a stronger revenue and profit in the second half of financial year 2024 (2H24) compared with 1H24.
This will be supported by potential monosodium methanearsonate (MSMA)-related trade diversions and commercialisation of Product T, the research house noted.
Uh-oh! Daily quota reached.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!